KEGG   DRUG: Purified Vi polysaccharide typhoid vaccine
Entry
D12923                      Drug                                   
Name
Purified Vi polysaccharide typhoid vaccine;
Typhim Vi (TN)
Product
Remark
Therapeutic category: 6311
ATC code: J07AP03
Product: D12923<JP/US>
Efficacy
Active immunization (typhoid)
  Disease
Typhoid fever [DS:H00111]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07A BACTERIAL VACCINES
    J07AP Typhoid vaccines
     J07AP03 Typhoid, purified polysaccharide antigen
      D12923  Purified Vi polysaccharide typhoid vaccine <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6311  Bacterial vaccines
     D12923  Purified Vi polysaccharide typhoid vaccine
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12923
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D12923
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12923
Other DBs
PubChem: 497621336
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system